Social anxiety disorder (SAD) is a common and debilitating condition that affects approximately 1 in 14 Americans at any given time. It is characterized by intense and constant fear of not being accepted by others and a sense of perpetual anxiety and self-doubt. Many people with SAD never seek treatment, and even those who do…
Many have been watching as the psychedelic renaissance has taken off and more clinical trials for psychedelic-assisted therapy have begun. Here at Portland Psychotherapy, our research team has been working tirelessly to prepare for our Clinical Trial of MDMA-Assisted Therapy for Social Anxiety Disorder (SAD), recently mentioned in the MAPS Investigator-Initiated Trial update here. Our…
A recent paper from Portland Psychotherapy researchers summarizes the results of the strongest research studies examining psychedelic-assisted therapy – placebo-controlled randomized clinical trials, the same kinds of studies that have been used to test COVID vaccines. Placebo-controlled randomized clinical trials are the “gold standard” for testing interventions – such as psychedelic-assisted psychotherapy – where participants…
What is Social Anxiety Disorder? We all know what it feels like to feel awkward or nervous in a social setting. Maybe you’ve felt jittery and noticed your heart speed up when introducing yourself to someone new. Perhaps you’ve noticed yourself blushing during a presentation at work or school. For most people, talking with a…
Measure 109 in Oregon was recently approved by voters, making Oregon the very first state in the U.S.A. to legalize psilocybin-assisted therapy. While many are eager to begin providing or receiving this breakthrough service, psilocybin-assisted therapy will not be officially available until sometime in 2023. This is because the Oregon Health Authority (OHA) will be in charge…
